SEC Form 4 reporting owner

Sandler Laura Lee

Sandler Laura Lee has filed 26 Form 4 transactions reported between January 2, 2026 and September 15, 2026, as Chief Operating Officer of Oruka Therapeutics, Inc..

Name as filed: Sandler Laura Lee

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.9M
19 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 15, 2026
transaction date

Roles and reported holdings

  • ORKAOruka Therapeutics, Inc.
    Jan 2, 2026 – Sep 15, 2026

    Chief Operating Officer

    Held directly235,478 sh as of Sep 15, 2026 · Form 4

    24 months: $1.9M sold

Transaction history

All 26 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 15, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct906$87K@ $95.71Form 4
Sep 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct4,000$368K@ $92.01Form 4
Sep 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct1,000$91K@ $91.05Form 4
Sep 1, 2026ORKAChief Operating OfficerOption exerciseCode M · direct5,000$39K@ $7.80Form 4
Jul 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct500$48K@ $95.47Form 4
Jul 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct2,263$214K@ $94.75Form 4
Jul 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct2,237$210K@ $93.85Form 4
Jul 1, 2026ORKAChief Operating OfficerOption exerciseCode M · direct5,000$39K@ $7.80Form 4
Jun 15, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct600$42K@ $69.69Form 4
May 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct100$7K@ $68.48Form 4
May 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct200$13K@ $67.16Form 4
May 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct400$26K@ $66.06Form 4
May 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct300$20K@ $65.10Form 4
May 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct1,800$115K@ $64.15Form 4
May 1, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct2,200$138K@ $62.58Form 4
May 1, 2026ORKAChief Operating OfficerOption exerciseCode M · direct5,000$39K@ $7.80Form 4
Mar 16, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct600$25K@ $41.30Form 4
Mar 2, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct2,675$90K@ $33.81Form 4
Mar 2, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct2,325$77K@ $33.28Form 4
Mar 2, 2026ORKAChief Operating OfficerOption exerciseCode M · direct5,000$39K@ $7.80Form 4
Jan 23, 2026ORKAChief Operating OfficerGrant or awardCode A · direct130,000—Form 4
Jan 23, 2026ORKAChief Operating OfficerGrant or awardCode A · direct32,500—Form 4
Jan 2, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct1,108$33K@ $29.75Form 4
Jan 2, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct3,144$91K@ $29.08Form 4
Jan 2, 2026ORKAChief Operating OfficerOpen-market saleCode S · direct8,748$246K@ $28.17Form 4
Jan 2, 2026ORKAChief Operating OfficerOption exerciseCode M · direct5,000$39K@ $7.80Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.